These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 27235322)
1. Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development. Halpern WG; Ameri M; Bowman CJ; Elwell MR; Mirsky ML; Oliver J; Regan KS; Remick AK; Sutherland VL; Thompson KE; Tremblay C; Yoshida M; Tomlinson L Toxicol Pathol; 2016 Aug; 44(6):789-809. PubMed ID: 27235322 [TBL] [Abstract][Full Text] [Related]
2. Scientific and Regulatory Policy Committee Points to Consider*: Review of Scientific and Regulatory Policy Committee Points to Consider: Review of Current Practices for Ultrastructural Pathology Evaluations in Support of Nonclinical Toxicology Studies. Keirstead ND; Janovitz EB; Meehan JT; LeRoy BE; Megill JR; Peterson RA; Masson RG; Marxfeld HA Toxicol Pathol; 2019 Jun; 47(4):461-468. PubMed ID: 31018785 [TBL] [Abstract][Full Text] [Related]
3. Scientific and Regulatory Policy Committee Points to Consider*: Approaches to the Conduct and Interpretation of Vaccine Safety Studies for Clinical and Anatomic Pathologists. Sellers RS; Nelson K; Bennet B; Wolf J; Tripathi N; Chamanza R; Perron Lepage MF; Adkins K; Laurent S; Troth SP Toxicol Pathol; 2020 Feb; 48(2):257-276. PubMed ID: 31594486 [TBL] [Abstract][Full Text] [Related]
4. Scientific and Regulatory Policy Committee Points to Consider: Review of the United States Food and Drug Administration (FDA) Guidance on Pathology Peer Review in Nonclinical Toxicology Studies. McDorman KS; Bennet BM; Colman K; Fikes JD; Keirstead ND; Lanning Retired L; Munch B; Romeike A; Schafer KA; Schorsch F; Thibodeau MS; Thomas HC; Troth S; Vahle JL; Geoly FJ Toxicol Pathol; 2024 Feb; 52(2-3):138-148. PubMed ID: 38840532 [TBL] [Abstract][Full Text] [Related]
5. Scientific and Regulatory Policy Committee Points to Consider: Integration of Clinical Pathology Data With Anatomic Pathology Data in Nonclinical Toxicology Studies. Siska W; Schultze AE; Ennulat D; Biddle K; Logan M; Adedeji AO; Arndt T; Aulbach A Vet Clin Pathol; 2022 Sep; 51(3):311-329. PubMed ID: 35975895 [TBL] [Abstract][Full Text] [Related]
6. Juvenile Toxicology: Relevance and Challenges for Toxicologists and Pathologists. Remick AK; Catlin NR; Quist EM; Steinbach TJ; Dixon D Toxicol Pathol; 2015 Dec; 43(8):1166-71. PubMed ID: 26220944 [TBL] [Abstract][Full Text] [Related]
7. Current Trends of Practices in Nonclinical Toxicology: An Industry Survey. Authier S; Brock WJ; Halpern W; Harris SN; Jones D; McGovern T; McGovern PD; Pugsley MK Int J Toxicol; 2021 Dec; 40(6):487-505. PubMed ID: 34569357 [TBL] [Abstract][Full Text] [Related]
8. Scientific and Regulatory Policy Committee Points to Consider: Integration of Clinical Pathology Data With Anatomic Pathology Data in Nonclinical Toxicology Studies. Siska W; Schultze AE; Ennulat D; Biddle K; Logan M; Adedeji AO; Arndt T; Aulbach AD Toxicol Pathol; 2022 Aug; 50(6):808-826. PubMed ID: 35852467 [TBL] [Abstract][Full Text] [Related]
9. Society of Toxicologic Pathology position paper on best practices on recovery studies: the role of the anatomic pathologist. Perry R; Farris G; Bienvenu JG; Dean C; Foley G; Mahrt C; Short B; Toxicol Pathol; 2013; 41(8):1159-69. PubMed ID: 23531793 [TBL] [Abstract][Full Text] [Related]
10. Response letter from Clinical Pathology Interest Group of the Society of Toxicologic Pathology (STP) for manuscript entitled International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies by Bolon et al. Tripathi NK; Schultze AE; Pearson RC; Everds NE; Elliott GS; Ramaiah L; Wells MY; Latimer KS; Walter GL; Katavolos P; Collins ND; Tarrant J; Walker DB; Topper MJ; Jordan HL; O'Rourke LG; Guilpin VB; Brockus CW; Wilcox AL; Clemo FA; Smith GS; Reagan WJ; McCartney JE Exp Toxicol Pathol; 2013 Jan; 65(1-2):39. PubMed ID: 21676604 [No Abstract] [Full Text] [Related]
11. Scientific and Regulatory Policy Committee Points to Consider: Data Visualization for Clinical and Anatomic Pathologists. Troth SP; Everds NE; Siska W; Knight B; Lamb M; Hutt J Toxicol Pathol; 2018 Jul; 46(5):476-487. PubMed ID: 29843574 [TBL] [Abstract][Full Text] [Related]
12. International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies. Bolon B; Barale-Thomas E; Bradley A; Ettlin RA; Franchi CA; George C; Giusti AM; Hall R; Jacobsen M; Konishi Y; Ledieu D; Morton D; Park JH; Scudamore CL; Tsuda H; Vijayasarathi SK; Wijnands MV Exp Toxicol Pathol; 2011 Jan; 63(1-2):187-95. PubMed ID: 20724123 [TBL] [Abstract][Full Text] [Related]
13. Scientific and Regulatory Policy Committee Best Practices: Documentation of Sexual Maturity by Microscopic Evaluation in Nonclinical Safety Studies. Vidal JD; Colman K; Bhaskaran M; de Rijk E; Fegley D; Halpern W; Jacob B; Kandori H; Manickam B; McKeag S; Parker GA; Regan KS; Sefing B; Thibodeau M; Vemireddi V; Werner J; Zalewska A Toxicol Pathol; 2021 Jul; 49(5):977-989. PubMed ID: 33661059 [TBL] [Abstract][Full Text] [Related]
14. Is It Adverse, Nonadverse, Adaptive, or Artifact? Pandiri AR; Kerlin RL; Mann PC; Everds NE; Sharma AK; Myers LP; Steinbach TJ Toxicol Pathol; 2017 Jan; 45(1):238-247. PubMed ID: 27770107 [TBL] [Abstract][Full Text] [Related]
16. Scientific and Regulatory Policy Committee Points to Consider: Primary Digital Histopathology Evaluation and Peer Review for Good Laboratory Practice (GLP) Nonclinical Toxicology Studies. Forest T; Aeffner F; Bangari DS; Bawa B; Carter J; Fikes J; High W; Hayashi SM; Jacobsen M; McKinney L; Rudmann D; Steinbach T; Schumacher V; Turner O; Ward JM; Willson CJ Toxicol Pathol; 2022 Jun; 50(4):531-543. PubMed ID: 35657014 [TBL] [Abstract][Full Text] [Related]
17. STP Best Practices for Evaluating Clinical Pathology in Pharmaceutical Recovery Studies. Tomlinson L; Ramaiah L; Tripathi NK; Barlow VG; Vitsky A; Poitout-Belissent FM; Bounous DI; Ennulat D Toxicol Pathol; 2016 Feb; 44(2):163-72. PubMed ID: 26879687 [TBL] [Abstract][Full Text] [Related]
18. Toxicologic Pathology Forum: Current Status on the Use of Animal Models of Human Disease in the Pharmaceutical Industry in Japan in Nonclinical Safety Assessment-Opinion Paper. Tomohiro M; Okabe T; Kimura Y; Kinoshita K; Maeda M; Mitobe Y; Motoyama K; Yonezawa R; Sasaki S; Fujiwara M; Watanabe K Toxicol Pathol; 2019 Feb; 47(2):108-120. PubMed ID: 30636562 [TBL] [Abstract][Full Text] [Related]
19. STP debate on the desirability of an international mechanism for recognizing qualified toxicologic pathologists. Bolon B; Ochoa R; Mann P Toxicol Pathol; 2009 Dec; 37(7):992-6. PubMed ID: 19820139 [TBL] [Abstract][Full Text] [Related]